Interview with Andreas Djamwari, President Director, Soho Group
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
Address: Jl. Rawa Sumur II Kav. B.B3 ,Kawasan Industri Pulo Gadung, Jakarta 13930 INDONESIA
Tel: +6221 4683 2588
Web: http://www.sohogroup.com/
SOHO Group, one of the prominent pharmaceutical corporations in Indonesia was set up in 1946 by an entrepreneur, the late Mr. Tan Tjhoen Lim.Nowadays, SOHO Group is one of Indonesia’s leading pharmaceutical and healthcare corporations in manufacturing, distributing, and providing quality health products and services. The corporation consists of two manufacturing companies: PT. SOHO Industri Pharmasi & PT. ETHICA Industri Farmasi, and a distribution company: PT. PARIT PADANG.It focus on manufacturing – including under-licensed – herbal products (immunomodulator, antioxidant, anti diarrhea, anti laxantia) and synthetic products (antibiotic, cephalosporin, injection preparation, antiemetic, analgesic, musculoskeletal, vitamin, obgyn, gastro, neuro, and rheumatology products)The distribution channel is supported by our 25 branches covering 90% of major cities in Indonesia. Soho Group is also present in other emerging markets: Malaysia, Myanmar, Nigeria, Lebanon, Mongolia. SOHO Group is also having and launching good quality and good prospect products from overseas, namely from Japan, Europe, Australia and the USA, through licensing activities.The revenue growth is 25% year-on-year since 2004. It employs around 3,000 people.
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
Many multinational companies have chosen to forgo establishing production facilities in Indonesia or have even shuttered their facilities, as did Janssen-Cilag. With the recent 10/10 decree, it seems the environment…
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
